ClearPoint Neuro, Inc. (CLPT) vs Profound Medical (PROF)

ClearPoint Neuro, Inc. and Profound Medical are both Medical Devices companies. ClearPoint Neuro, Inc. is the larger, with a market value of $278.6M against $251.3M — 1.1× the size. Profound Medical grew revenue faster over the last twelve months: 65.3% against 32.5%. ClearPoint Neuro, Inc. has the higher net margin (−79.4% vs −137.5%) and the higher return on invested capital (−62.8% vs −156.6%). Across the 18 metrics below, ClearPoint Neuro, Inc. leads on 11 and Profound Medical on 7.

Valuation

Metric CLPT PROF Medical Devices median
P/E n/m n/m 25.58
P/S 5.92 10.63 2.54
P/B 9.87 5.91 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 6.02 9.60 2.72
Earnings yield (13.93%) (13.55%) (12.82%)
Free cash flow yield (12.54%) (12.80%) (8.18%)

Profitability

Metric CLPT PROF Medical Devices median
Gross margin 61.39% 73.86% 57.76%
Operating margin (70.56%) (145.08%) (15.07%)
Net margin (79.43%) (137.51%) (14.45%)
Free cash flow margin (73.02%) (133.29%) (3.88%)
Return on equity (167.52%) (87.04%) (10.35%)
Return on assets (41.75%) (64.68%) (17.26%)
Return on invested capital (62.84%) (156.58%) (5.27%)

Growth

Metric CLPT PROF Medical Devices median
Revenue growth (TTM) 32.51% 65.26% 10.41%
EPS growth (last fiscal year) (28.57%) (25.89%) 28.17%
Revenue growth, 5-year CAGR 23.58% 17.12% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLPT PROF Medical Devices median
Debt to equity 1.86 0.11 0.04
Current ratio 6.76 4.54 2.74
Net debt to EBITDA (0.14) 1.36 0.54

Dividend

Metric CLPT PROF Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric CLPT PROF Medical Devices median
Market cap 278.55m 251.33m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack